Man Group PLC Amneal Pharmaceuticals, Inc. Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

A detailed history of Man Group PLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Man Group PLC holds 121,792 shares of AMRX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

121,792

Previous 27,529 342.41%

Holding current value

$1.09 Million

Previous $229,000 320.96%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.69 - $9.25 $724,882 - $871,932	94,263 Added 342.41%	121,792 $964,000
Q3 2024 Nov 14, 2024	BUY	$6.42 - $8.83 $176,736 - $243,081	27,529 New	27,529 $229,000
Q1 2023 May 15, 2023	BUY	$1.27 - $2.7 $73,816 - $156,932	58,123 Added 105.39%	113,274 $157,000
Q4 2022 Feb 14, 2023	BUY	$1.96 - $2.61 $57,718 - $76,859	29,448 Added 114.57%	55,151 $109,000
Q3 2022 Nov 14, 2022	BUY	$2.02 - $3.62 $51,920 - $93,044	25,703 New	25,703 $52,000
Q2 2022 Aug 15, 2022	SELL	$3.01 - $4.46 $65,994 - $97,785	-21,925 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.9 - $4.89 $35,306 - $44,269	9,053 Added 70.33%	21,925 $91,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $3,709 - $5,493	939 Added 7.87%	12,872 $62,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $5,279 - $6,909	-1,225 Reduced 9.31%	11,933 $64,000
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $67,368 - $89,737	13,158 New	13,158 $67,000
Q1 2019 May 15, 2019	SELL	$11.87 - $14.84 $1.08 Million - $1.36 Million	-91,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.09 - $21.49 $1.2 Million - $1.96 Million	91,400 New	91,400 $1.24 Million

Others Institutions Holding AMRX

# of Institutions

205

Shares Held

124M

Call Options Held

362K

Put Options Held

141K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.36B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account